Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy

Van Staa, T. P., Laan, R. F., Barton, I. P., Cohen, S., Reid, D. M., Cooper, C.·2003·Arthritis & Rheumatism
DOI 10.1002/art.11283

Cited by (556)

Items 501–556 of 556

  1. Les bisphosphonates dans l’ostéoporose cortico-induite : efficacité et tolérance
    Éric Lespessailles · 2013 · Revue du Rhumatisme
  2. Osteoporosis inducida por corticoides
    Christian Marcelli · 2011 · EMC - Aparato Locomotor
  3. Pediatric Bone and Adult Bone - Physiological Differences
    Francisco A. Sylvester, Erica L. Wynn · 2013 · Wiley eBooks
  4. Osteoporosis: Beyond Bone Mineral Density (Part II)
    John O. Neustadt, Steve R. Pieczenik · 2009
  5. osteoporosis: an update on current pharmacotherapy and future directions
    Irene E. M. Bultink, Marijke Baden, Willem Frederik Lems · 2013
  6. Pharmaka mit negativer Auswirkung auf den Knochen - durch Medikamente induzierte Osteoporose
    Gasser Rw, Claudia Götsch · 2016 · Journal für Kardiologie (Krause & Pachernegg GmbH)
  7. Prévention et traitement de l'ostéoporose cortico-induite
    S. Grunenwald · 2007 · Annales d Endocrinologie
  8. Гл юкокортикоидный остеопороз: особенности терапии
    Natalia V. Toroptsova, Irina Aleksandrovna Baranova · 2013 · CyberLeninK (CyberLeninka)
  9. PROFESSEURS DES UNIVERSITES - PRATICIENS HOSPITALIERS
    P. Fréger, Michel Guerbet, Benoît Veber, P. Joly, Stéphane Marret · 2015
  10. Ankle pain in a young woman with Gaucher disease
    Ajoe John Kattoor, Thomas W. Bauer, Mark Jacob Berkowitz, Joshua M. Polster, Alan Eli Lichtin · 2015 · Cleveland Clinic Journal of Medicine
  11. Parathyroid Hormone and Glucocorticoid-induced Osteoporosis
    Robert A. Adler, Andrea Giustina · 2014 · Elsevier eBooks
  12. 13 Systemische Osteopathien
    Gabriele Lehmann · 2011 · De Gruyter eBooks
  13. Avaluació de la prevalença d’ús de medicaments en pacients que acudeixen a un servei d’urgències d’un hospital amb fractures per fragilitat òssia
    Gorgas Torner, M.A. Valero Queralt · 2016 · TDX (Tesis Doctorals en Xarxa)
  14. Zelluläre Mechanismen der Gluko-kortikoid-induzierten Osteoporose und therapeutische Ansatzpunkte
    Sylvia Jane Gasparini, Hong Zhou, Lorenz Christian Hofbauer, Markus J. Seibel, Holger Henneicke · 2016 · Osteologie/Osteology
  15. GLOMERULONEFRITŲ IMUNOSUPRESINIO GYDYMO KOMPLIKACIJOS
    Evaldas Tytmonas, Artūras Vinikovas, Ernesta Mačionienė, Marius Miglinas, Laurynas Rimševičius · 2017 · Medicinos teorija ir praktika
  16. Glucocorticoid induced osteoporosis and mechanisms of intervention
    Amy Y. Sato · 2017 · IUScholarWorks (Indiana University)
  17. GH/IGF-I and Bone
    Stefano Frara, Filippo Maffezzoni, Mauro Doga, Anna Maria Formenti, Gherardo Mazziotti, Andrea Giustina · 2018 · Springer eBooks
  18. Metabolic Bone Disease in Gastrointestinal Disorders
    Ann Cranney, Alaa Rostom, Catherine Dubé, Rachid Mohamed, Peter Tugwell, George A. Wells, John WD McDonald · 2010 · Wiley eBooks
  19. Metabolic Bone Disease in Gastrointestinal Disorders
    Herman Bami, Arthur N. Lau, Jonathan Derrick Adachi · 2019 · Wiley eBooks
  20. Rolle von Single-Nukleotid-Polymorphismen der 11beta-Hydroxysteroid-Dehydrogenase in Bezug auf den Glucocorticoidstoffwechsel im Knochen – Einfluss auf den supprimierten Cortisolspiegel und die Knochendichte bei Osteoporosepatienten
    Michael Etmanski · 2019
  21. Osteoporose induzida por glicocorticoides: expressão salivar de biomarcadores ósseos em pacientes submetidos à corticoterapia prolongada e sua correlação radiomorfométrica
    Cibele Pidorodeski Nagano · 2019
  22. Osteonecrosis and bone health in children, teenagers and young people with leukaemia
    Nadia Laila Amin · 2019 · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
  23. Valutazione del rischio di frattura ossea
    Edda Vignali, Claudio Marcocci · 2020 · L Endocrinologo
  24. Glucocorticoid-induced osteoporosis and Cushing’s syndrome
    Kenneth G. Saag, Robert A. Adler, Robert S. Weinstein · 2020 · Elsevier eBooks
  25. Riesgo de fracturas en pacientes con enfermedades reumáticas en tratamiento con corticoides orales crónicos
    Ana María Bertoli, Martín Córdoba · 2021 · Methodo Investigación Aplicada a las Ciencias Biológicas
  26. Bones and Rheumatology
    Altaf A. Abdulkhaliq · 2021 · Springer eBooks
  27. Compromiso cardiovascular y trombótico en COVID-19. Implicancias clínicas y terapéuticas
    Raúl J. Barcudi, Julio Bono, Pablo Ezequiel Sarmiento · 2021 · Methodo Investigación Aplicada a las Ciencias Biológicas
  28. Faut-il (vraiment) mettre en route un traitement préventif de l’ostéoporose pour toutes les patientes ménopausées recevant une corticothérapie ?
    François Robin, Alain Lescoat, P. Jégo, Pascal Guggenbuhl · 2021 · La Revue de Médecine Interne
  29. Glucocorticoids and Musculoskeletal Health
    Yasser M El Miedany · 2022 · Springer eBooks
  30. Osteoporosis
    Kenneth G. Saag, Sarah L. Morgan, Amy H. Warriner · 2009 · Springer eBooks
  31. Glucocorticoids
    Melissa Northcott, Eric Francis Morand · 2021 · Elsevier eBooks
  32. Multivariate analysis of risk factors for major osteoporotic fracture risk assessed with radiofrequency echographic multi spectrometry (REMS)
    Stoyanka Vladeva, N. Nikolov · 2022 · Rheumatology (Bulgaria)
  33. Faculty Opinions recommendation of Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trial.
    Toshio Matsumoto · 2013 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  34. Osteoporosis
    Piet Geusens · 2011 · Elsevier eBooks
  35. Osteoporose bei systemischer Mastozytose: Eine Kohortenstude mit 43 Patienten
    N. Schmidt · 2022
  36. Prevention of Adverse Outcomes and Treatment Side Effects in Patients with Neuromuscular Disorders
    Kavita Mohindra Grover, Naganand Sripathi · 2022 · Seminars in Neurology
  37. Dual-Energy X-Ray Absorptiometry Scan Utilization and Skeletal Fragility Among Non-Infectious Uveitis Patients Exposed to Oral Glucocorticoids
    Nicholas J. Butler, Devin C. Cohen, Yinxi Yu, John H. Kempen, Lucia Sobrin, Brian L. VanderBeek · 2023 · Ocular Immunology and Inflammation
  38. Parabiosis reinvigorates age-related bone quality through Wnt/β-catenin signaling
    Ruibing Feng, Tiantian Yu, Xiaofeng Duan, Gang Wu, Yong Huang, Hao Hu · 2023 · Research Square
  39. Bone mineral density and skeletal outcomes in congenital adrenal hyperplasia
    Cemre Robinson, Tony Yuen, Mone Zaidi · 2023 · Elsevier eBooks
  40. The Severity of Bone Loss in Cushing’s Diseases
    Wissame Debbah, Mouna Mezoued, Aicha Bouzid, Randa Talhi, Khadidja Bessaid, Malha Azzouz · 2024 · International Journal of Diabetes and Endocrinology
  41. Examining the Relationship between Depressive Symptoms and Osteoporosis in Middle-Aged and Older Adults: A 6-Year Regression and 8-Year Trajectory Analysis from Elsa and Hrs Cohorts
    Zheng Lian, Kai Zhu, Shuo Han, Changpeng Qu, Kunpeng Su, Xuexiao Ma, Hao Tao · 2025 · SSRN Electronic Journal
  42. Phytotherapy Targeting Rheumatoid Arthritis: A Clinically Based Approach
    G. Zugravu, Anca Miron · 2025 · Journal of Medicinal Natural Products
  43. Dexamethasone-Induced Osteoblast Toxicity: Bioenergetics Dysfunction and Oxidative Stress Unmask Apoptotic Pathways
    Ekramy Mahmoud Elmorsy, Ayat B Al Ghafari, Huda Abdulaziz Al Doghaither, Majed Gorayan Alrowaili, Zenat Ahmed Khired, Manal Said Fawzy, Shaimaa A. Shehata · 2025 · Indian Journal of Pharmaceutical Education and Research
  44. The Use of FRAX® in DXA Interpretation
    S. M. Ploof, Scott D. Wuertzer, Leon Lenchik · 2013 · Medical radiology
  45. Additional file 2 of Sex and age do not modify the association between glucocorticoids and bone mineral density in patients with rheumatoid arthritis: a cross-sectional study
    Andriko Palmowski, Zhivana Boyadzhieva, Sabrina Mai Nielsen, Burkhard Muche, Sandra Hermann, Maarten Boers, Bliddal, Henning, Christensen, Robin, Edgar Wiebe, Frank Buttgereit · 2024 · Figshare
  46. Additional file 1 of Sex and age do not modify the association between glucocorticoids and bone mineral density in patients with rheumatoid arthritis: a cross-sectional study
    Andriko Palmowski, Zhivana Boyadzhieva, Sabrina Mai Nielsen, Burkhard Muche, Sandra Hermann, Maarten Boers, Bliddal, Henning, Christensen, Robin, Edgar Wiebe, Frank Buttgereit · 2024 · Figshare
  47. Cushing's syndrome, glucocorticoids and bone
    Michal Kršek · 2019 · Clinical Osteology
  48. Osteoporosis and fractures in multiple sclerosis: pathogenesis, risk factors, treatment options, and prevention
    Vít Zikán, Ivana Kvasničková, Michaela Týblová · 2018 · Clinical Osteology
  49. Secondary Osteoporosis
    Pavel Hořák · 2025 · Clinical Osteology
  50. Autoimmune liver diseases in older adults: Clinical challenges and management considerations
    Pablo Guillermo Hernández-Almonacid, Juan Sebastian Espejo-Amado, Ximena Marín-Quintero · 2026 · World Journal of Hepatology
  51. Osteoimmunology: Can We Prevent Bone Loss in Rheumatoid Arthritis with Modern Antirheumatic Drugs?
    Hennie G. Raterman, Giovanni Adami, Patricia Clark, Glenn Haugeberg, Jorge Morales Torres, Luis Vidal Neira, Leïth Zakraoui, Cristiano A. F. Zerbini, Osvaldo Daniel Messina, Willem Frederik Lems et al. · 2026 · Calcified Tissue International
  52. Medikamente mit einem erhöhten Risiko für den Knochen
    Rudolf Wolfgang Gasser · 2026 · Journal für Endokrinologie Diabetologie und Stoffwechsel
  53. Osteoporose induzida por glicocorticoide (OPIG)
    Alex Rocha Bernardes da Silva · 2025 · Revista Paulista de Reumatologia
  54. Update in Diagnosis and Management of Glucocorticoid-Induced Osteoporosis
    Anthea Chung, Ka Man Chan · 2026 · Journal of Clinical Rheumatology and Immunology
  55. Plasma Metal Concentration is Sex Dependent and Associated with Fragility Fractures: Results of METOSTEO Cohort
    François Robin, Alexandre Mercier-Guery, Simon Cadiou, Alexia Leloix, Marie‐Laure Island, Olivia Berthoud, Martine Ropert, Olivier Loréal, Pascal Guggenbuhl · 2026 · Biological Trace Element Research
  56. Effectiveness of anti-osteoporotic medications in the management of glucocorticoid-induced osteoporosis: a systematic review and network meta-analysis on behalf of the ECTS clinical action group
    Maria P. Yavropoulou, Marieke M. ter Wee, Anda Mihaela Naciu, Julien Paccou, Athanasios D. Anastasilakis, Chrysoula G. Gialouri, Barbara Hauser, Anne Sophie Sølling, Stella D’Oronzo, Tim Rolvien et al. · 2026 · European Journal of Endocrinology